FDA Inspection 1102180 — Medtronic Neuromodulation
The FDA completed an inspection of Medtronic Neuromodulation on Aug 6, 2019 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 6, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Minneapolis, MN (United States)